Koninklijke DSM NV Financials

Koninklijke DSM Stock Summary

Koninklijke DSM competes with Sika AG, Symrise AG, Shin-Etsu Chemical, LAir Liquide, and Givaudan. Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people.

Koninklijke DSM Key Financial Ratios

There are many critical financial ratios that Koninklijke DSM's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Koninklijke DSM NV reports annually and quarterly.

Koninklijke Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Koninklijke DSM's current stock value. Our valuation model uses many indicators to compare Koninklijke DSM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Koninklijke DSM competition to find correlations between indicators driving Koninklijke DSM's intrinsic value. More Info.Koninklijke DSM NV is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  0.34  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Koninklijke DSM NV is roughly  2.96 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Koninklijke DSM's earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.